RecallDepth

ADVIA 1650 Chemistry System, Automated Clinical Chemistry Analyzer - human serum, plasma and urine tests.

Company
Bayer Healthcare, Llc (Diagnostics Division)
Recall Initiated
February 17, 2006
Posted
August 29, 2006
Terminated
May 24, 2012
Recall Number
Z-1448-06
Quantity
1138 for all products
Firm Location
Tarrytown, NY

Reason for Recall

Low QC recovery observed on carbamazepine (CARB) results immediately following a Gentamicin (GENT) assay or a Digoxin (DIG) assay. When GENT or DIG precedes CARB, the CARB test result is artificially low (as much as -25%). PHNY was determined to also exhibit a similar carryover effect on CARB. All others were found not to produce the same reagent probe-based carryover effect.

Distribution

Worldwide including USA and Puerto Rico.

Lot / Code Info

Part No. 073-A001; all Advia Chemistry System units and serial numbers are involved in this ''field correction'' as well as existing assay lots for CARB, PHNY, GENT and DIG.

Root Cause

Other

Action Taken

Bayer HealthCare LLC issued a Support Bulletin to all affected Bayer HealthCare LLC Branches on/about 2/17/06 in order to inform them of the issue and to provide them with instructions for this ''field correction''. Customer Bulletins were also issued to the Branches both in the United States and elsewhere for communication with the affected customers.

More recalls by Bayer Healthcare, Llc (Diagnostics Division)

View all recalls by this company →